NCT05469841

Brief Summary

Pain is a frequent symptom in the intensive care unit (ICU). Critical ill patients are often intubated and sedated which makes self-evaluation of pain impossible. Pupillary dilatation is a reflex directly related to stimuli such as pain, which can be measured by quantitative pupillometry. Several studies in ICU showed a significant relationship between pupillary diameter variation and pain. The nociception level index (NOL-index) is a recent noninvasive and continuous monitoring of pain essentially used in operating room. The aim of this study is to evaluate the pupillometry and NOL index in critical ill patients in sedated patients under mechanical ventilation during the mobilization plus toilet (described in literature as not painful procedure) and tracheal suctioning (described as a painful procedure)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 20, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 22, 2022

Completed
7 days until next milestone

Study Start

First participant enrolled

July 29, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 28, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 28, 2023

Completed
Last Updated

April 3, 2023

Status Verified

March 1, 2023

Enrollment Period

8 months

First QC Date

June 20, 2022

Last Update Submit

March 31, 2023

Conditions

Keywords

painintensive caresedatedventilatedNOL ICUpupillometry

Outcome Measures

Primary Outcomes (1)

  • pupillary redilatation velocity after constriction light-induced

    Area under the ROC curve (AUC) of pupillary re-dilation velocity measured before a potentially painful procedure to predict the occurrence of a BPS score ≥ 5 during the procedure.

    1 hour during procedure

Secondary Outcomes (5)

  • Nociception Level index

    1 hour during procedure

  • Systolic and diastolic Blood pressure

    1 hour during procedure

  • Heart rate

    1 hour during procedure

  • Respiratory rate

    1 hour during procedure

  • Behaviour Pain Scale

    1 hour during procedure

Study Arms (1)

Pupillometry

EXPERIMENTAL

Pain will be evaluated via pupillometry with 3 successive measurements

Other: Systemic pain assessment

Interventions

Pain will be evaluated via i) pupillometry with 3 successive measurements ii) Behaviour Pain Scale (BPS) and Critical Care Pain Observation Tool (CPOT) score evaluated by an investigator (physician) iii) evolution of physiological parameters (ie heart rate, blood pressure, respiratory rate) iv) Nociception Level Index (NOL) index.

Pupillometry

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • older than18 years old
  • Under invasive mechanical ventilation
  • Sedated with i) a Richmond Agitation Sedation Scale (RASS) : ≥ -4 and \<1, ii) being unable to evaluate their pain by a visual numeric scale

You may not qualify if:

  • Ophthalmological diseases which could modify the pupillometric parameters
  • Neurological diseases (damage of nerve III, intracranial hypertension, stroke)
  • Admitted in ICU after resuscitated cardiac arrest
  • Drugs that inhibit the effect of the sympathetic system (clonidine, dexmedetomidine)
  • Patient under Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO)
  • Patient treated by a neuromuscular blockade
  • A do-not resuscitate order
  • Major hemodynamic instability prohibiting planned care procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Regional Hospital Center

Orléans, 45067, France

Location

Universitary Hospital Center

Tours, 37000, France

Location

MeSH Terms

Conditions

Critical IllnessPain

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Mai Anh NAY, MD

    Regional Hospital Center of ORLEANS

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 20, 2022

First Posted

July 22, 2022

Study Start

July 29, 2022

Primary Completion

March 28, 2023

Study Completion

March 28, 2023

Last Updated

April 3, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations